3D-Printed Organs Market is encountering new opportunities & technological advancements by Key Market Players (REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc., Digilab Inc., TeVido BioDevices) | Forecast to 2030

3D-Printed Organs Market Scope:
Market size value in 2023 - USD 2.13 Billion
Market size value in 2030 - USD 2.99 Billion
CAGR (2023-2030) - 18.51%
Forecast Period - 2023-2030
Segments Covered - Organ Type, Technology, Material Type, Application, End-user & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - TeVido BioDevices, Aspect Biosystems Ltd., Cyfuse Biomedical K.K., CELLINK GLOBAL, 3D Systems, BioBots, Rokit Healthcare, Tissue Regenix Group, LIFE 3D.

Download Sample Pages-https://www.marketdigits.com/request/sample/115

Browse in-depth TOC on "3D-Printed Organs Market"
178-Tables
95-Figures
332-Pages

North America dominates the market for 3D-Printed Organs.
In 2023, North America takes the lead in the 3D-printed organs market, trailed by Europe and Asia-Pacific. The North American region is characterized by a heightened incidence of chronic ailments like heart disease, cancer, and diabetes. These conditions often culminate in organ failure, significantly propelling the demand for 3D-printed organs. Substantial investments from both governmental bodies and private organizations in North America are channeled into the research and development of 3D-printed organs. Consequently, this momentum fuels the emergence of novel and advanced 3D printing technologies, facilitating the creation of intricate and lifelike organs. In the realm of North American 3D-printed organs, prominent players such as Organovo Holdings, Inc., RegenHU, Inc., and 3D Bioprinting Solutions, Inc., hold sway. These entities commit substantial resources to research and development endeavors, propelling innovation and ushering innovative products into the market.
Asia-Pacific is poised to undergo swift expansion within the 3D-printed organs market. Demonstrating an exceptional propensity for embracing novel technologies, the region is adept at rapidly assimilating innovations. This predisposition positions the area favorably to harness advancements in 3D printing, particularly in the realm of organ fabrication. The region's densely populated and diverse demographics provides an extensive reservoir of potential patients for organ transplants. This substantial recipient pool fosters a heightened demand for forward-looking solutions like 3D-printed organs. Furthermore, numerous countries in Asia-Pacific have made remarkable advancements in medical research and healthcare innovation. The synergy of medical expertise with cutting-edge 3D printing technology is expected to expedite both the development and adoption of 3D-printed organs. In light of these factors, it is anticipated that Asia-Pacific will observe a notable upswing in research, developmental initiatives, and the incorporation of 3D-printed organs in the years to come. This trajectory is poised to significantly contribute to the accelerated expansion of the market across the region.

Ask for Discount- https://www.marketdigits.com/request/discount/115

Top Key Players Covered in the Report-
Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc., Medprin Regenerative Medical Technologies Co., Ltd, EnvisionTEC, nScrypt, Advanced Solutions, Inc., Digilab Inc., TeVido BioDevices, Aspect Biosystems Ltd., Cyfuse Biomedical K.K., CELLINK GLOBAL, 3D Systems, BioBots, Rokit Healthcare, Tissue Regenix Group, LIFE 3D and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/115

Recent Developments-
• In May 2023, Bioprinting Solutions announced that it had partnered with the University of California, San Francisco to develop 3D-printed heart tissue. The partnership will use the university's expertise in heart disease to develop tissue that can be used to repair damaged hearts.
• In April 2023, Organovo Holdings announced that it had received FDA approval to begin clinical trials of its 3D-printed bladder tissue. The trials will test the safety and effectiveness of the tissue in patients with bladder cancer.

https://industrytoday.co.uk/market-research-industry-today/3d-printed-organs-market-is-experiencing-new-opportunities-competitive-edge-highlighted-by-top-market-key-players-organovo-holdings-inc-modern-meadow-poietis-regemat-3d-sl-cellbricks-nano3d-biosciences-inc-forecast-to-2030

Market Digits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.